This Article Full Text (OnlineFirst PDF) All Versions of this Article: 0003319708319781v1 60/2/221    most recent Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Nambiar, S. Articles by Magadi, S. Search for Related Content PubMed PubMed Citation Articles by Nambiar, S. Articles by Magadi, S. Social Bookmarking                         What's this?

Oxidative Stress in Prehypertension: Rationale for Antioxidant Clinical Trials

^* To whom correspondence should be addressed. E-mail: zacbobby{at}yahoo.com.

	Abstract

Prehypertension has been recently described as an independent category of blood pressure. Mounting evidence suggests that blood pressure in the prehypertensive range is associated with an increased risk of developing hypertension and cardiovascular disease. Several reports have assigned a critical role for oxidative stress in these disease processes. This review focuses on the clinical and experimental studies done in prehypertension and hypertension within the context of oxidative stress. This article also provides insights into why diverse therapeutic interventions, which have in common the ability to reduce oxidative stress, can impede or delay the onset of hypertension in prehypertension subjects.

First published on September 15, 2008, doi:10.1177/0003319708319781

Angiology 2009;60:221.

A more recent version of this article appeared on April 1, 2009


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?